Skip to main content
Top
Published in: International Urology and Nephrology 5/2016

01-05-2016 | Urology - Original Paper

Oncological outcomes and prognostic factors after nephron-sparing surgery in renal cell carcinoma

Authors: Miguel Ángel López-Costea, Xavier Bonet, Jose Pérez-Reggeti, Begoña Etcheverry, Francisco Vigués

Published in: International Urology and Nephrology | Issue 5/2016

Login to get access

Abstract

Purpose

To analyse the mid-term oncological results and to asses predictive factors for recurrence and survival after nephron-sparing surgery (NSS) for renal cell carcinoma.

Materials and methods

This is a retrospective study that includes 198 Partial Nephrectomies performed at our institution for malignant renal tumours. Demographic information and pathological characteristics were obtained, and completed statistical analysis was performed to assess predictors for overall survival (OS) and overall recurrence in our sample.

Results

The presence of positive surgical margins (PSM) in the surgical specimen was reported in 13.6 %. At a median of follow-up of 56.1 months, the non-adjusted cancer-specific mortality, DSS and OS were 100, and 93.4 %, respectively. In the bivariate analysis regarding predictive factors for recurrence, bilaterality and NSS indication (elective or imperative) were statistically significant (p = 0.03 and p = 0.05 respectively). On multivariate analysis only bilaterality was a significant predictor of recurrence (p = 0.03), while high Fuhrman grade was for survival (p = 0.006).

Conclusion

Our data suggest that patients with bilateral tumours have a higher incidence of local recurrence. Regarding overall survival, our data showed more risk of death at 5 years in those patients with high Fuhrman grade. No differences were found among PSM and negative surgical margins patients regarding oncological outcomes.
Literature
1.
go back to reference Lerner SE, Hawkins CA, Blute ML et al (1996) Disease outcome in patients with low stage renal cell carcinoma treated with nephron-sparing or radical surgery. J Urol 155:1868–1873CrossRefPubMed Lerner SE, Hawkins CA, Blute ML et al (1996) Disease outcome in patients with low stage renal cell carcinoma treated with nephron-sparing or radical surgery. J Urol 155:1868–1873CrossRefPubMed
2.
go back to reference Fergany AF, Hafez KS, Novick AC (2000) Longterm results of nephron-sparing surgery for localized renal cell carcinoma: 10-year follow-up. J Urol 163:442–445CrossRefPubMed Fergany AF, Hafez KS, Novick AC (2000) Longterm results of nephron-sparing surgery for localized renal cell carcinoma: 10-year follow-up. J Urol 163:442–445CrossRefPubMed
3.
go back to reference Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P (2000) Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol 163:730–736CrossRefPubMed Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P (2000) Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol 163:730–736CrossRefPubMed
4.
go back to reference Mitchell RE, Gilbert SM, Murphy AM, Olsson CA, Benson MC, McKiernan JM (2006) Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology 67:260–264CrossRefPubMed Mitchell RE, Gilbert SM, Murphy AM, Olsson CA, Benson MC, McKiernan JM (2006) Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology 67:260–264CrossRefPubMed
5.
go back to reference Carini M, Minervini A, Lapini A, Masieri L, Serni S (2006) Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival. J Urol 175:2022–2026CrossRefPubMed Carini M, Minervini A, Lapini A, Masieri L, Serni S (2006) Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival. J Urol 175:2022–2026CrossRefPubMed
6.
go back to reference Dash A, Vickers AJ, Schacter LR, Bach AM, Snyder ME, Russo P (2006) Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4–7 cm. BJU Int 97:939–945CrossRefPubMed Dash A, Vickers AJ, Schacter LR, Bach AM, Snyder ME, Russo P (2006) Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4–7 cm. BJU Int 97:939–945CrossRefPubMed
7.
go back to reference Patard JJ, Shvarts O, Lam JS et al (2004) Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 171:2181–2185CrossRefPubMed Patard JJ, Shvarts O, Lam JS et al (2004) Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 171:2181–2185CrossRefPubMed
8.
go back to reference Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H (2004) Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 171:1066–1070CrossRefPubMed Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H (2004) Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 171:1066–1070CrossRefPubMed
9.
go back to reference Go AS, Chertow GM, Fan D et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed Go AS, Chertow GM, Fan D et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed
10.
go back to reference Weight CJ, Larson BT, Fergany AF et al (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 183:1317–1323CrossRefPubMed Weight CJ, Larson BT, Fergany AF et al (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 183:1317–1323CrossRefPubMed
11.
go back to reference Lopez-Costea MA, Fumadó L, Lorente D et al (2010) Positive margins after nephron-sparing surgery for renal cell carcinoma: long-term follow-up of patients on active surveillance. BJU Int 106:645–648CrossRefPubMed Lopez-Costea MA, Fumadó L, Lorente D et al (2010) Positive margins after nephron-sparing surgery for renal cell carcinoma: long-term follow-up of patients on active surveillance. BJU Int 106:645–648CrossRefPubMed
12.
go back to reference Saranchuk JW, Touijer AK, Hakimian P et al (2004) Partial nephrectomy for patients with a solitary kidney: the Memorial Sloan-Kettering experience. BJU Int 94:1323–1328CrossRefPubMed Saranchuk JW, Touijer AK, Hakimian P et al (2004) Partial nephrectomy for patients with a solitary kidney: the Memorial Sloan-Kettering experience. BJU Int 94:1323–1328CrossRefPubMed
13.
go back to reference Yossepowitch O, Thompson RH, Leibovich BC et al (2008) Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 179:2158–2163CrossRefPubMedPubMedCentral Yossepowitch O, Thompson RH, Leibovich BC et al (2008) Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 179:2158–2163CrossRefPubMedPubMedCentral
14.
go back to reference Marszalek M, Carini M, Chlosta P et al (2012) Positive surgical margins after nephron-sparing surgery. Eur Urol 61:757–763CrossRefPubMed Marszalek M, Carini M, Chlosta P et al (2012) Positive surgical margins after nephron-sparing surgery. Eur Urol 61:757–763CrossRefPubMed
15.
go back to reference Peycelon M, Hupertan V, Comperat E et al (2009) Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm. J Urol 181:35–41CrossRefPubMed Peycelon M, Hupertan V, Comperat E et al (2009) Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm. J Urol 181:35–41CrossRefPubMed
16.
go back to reference Benway BM, Bhayani SB, Rogers CG et al (2009) Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumours: a multi-institutional analysis of perioperative outcomes. J Urol 182:866–872CrossRefPubMed Benway BM, Bhayani SB, Rogers CG et al (2009) Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumours: a multi-institutional analysis of perioperative outcomes. J Urol 182:866–872CrossRefPubMed
17.
go back to reference Ani I, Finelli A, Alibhai SM, Timilshina N, Fleshner N, Abouassaly R (2013) Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study. BJU Int 111(8):E300–E305CrossRefPubMed Ani I, Finelli A, Alibhai SM, Timilshina N, Fleshner N, Abouassaly R (2013) Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study. BJU Int 111(8):E300–E305CrossRefPubMed
18.
go back to reference Kwon EO, Carver BS, Snyder ME, Russo P (2007) Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours. BJU Int 99:286–289CrossRefPubMed Kwon EO, Carver BS, Snyder ME, Russo P (2007) Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours. BJU Int 99:286–289CrossRefPubMed
19.
go back to reference Duvdevani M, Mor Y, Kastin A et al (2006) Renal artery occlusion during nephron-sparing surgery: retrospective review of 301 cases. Urology 68:960–963CrossRefPubMed Duvdevani M, Mor Y, Kastin A et al (2006) Renal artery occlusion during nephron-sparing surgery: retrospective review of 301 cases. Urology 68:960–963CrossRefPubMed
20.
21.
go back to reference Mottrie A, De Naeyer G, Schatteman P, Carpentier P, Sangalli M, Ficarra V (2010) Impact of the learning curve on perioperative outcomes in patients who underwent robotic partial nephrectomy for parenchymal renal tumours. Eur Urol 58:127–133CrossRefPubMed Mottrie A, De Naeyer G, Schatteman P, Carpentier P, Sangalli M, Ficarra V (2010) Impact of the learning curve on perioperative outcomes in patients who underwent robotic partial nephrectomy for parenchymal renal tumours. Eur Urol 58:127–133CrossRefPubMed
22.
go back to reference Klaassen Z, Ostrowski A, Madi R, Terris MK (2013) Words of Wisdom: re: is near infrared fluorescence imaging using indocyanine green dye useful in robotic partial nephrectomy: a prospective comparative study of 94 patients. Eur Urol 63(3):581–582CrossRefPubMed Klaassen Z, Ostrowski A, Madi R, Terris MK (2013) Words of Wisdom: re: is near infrared fluorescence imaging using indocyanine green dye useful in robotic partial nephrectomy: a prospective comparative study of 94 patients. Eur Urol 63(3):581–582CrossRefPubMed
23.
go back to reference Bensalah K, Pantuck AJ, Rioux-Leclercq N et al (2010) Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol 57:466–473CrossRefPubMed Bensalah K, Pantuck AJ, Rioux-Leclercq N et al (2010) Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol 57:466–473CrossRefPubMed
24.
go back to reference Khalifeh A, Autorino R, Eyraud R, Samarasekera D, Laydner H, Panumatrassamee K, Stein RJ, Kaouk JH (2013) Three-year oncologic and renal functional outcomes after robot-assisted partial nephrectomy. Eur Urol 64(5):744–750CrossRefPubMed Khalifeh A, Autorino R, Eyraud R, Samarasekera D, Laydner H, Panumatrassamee K, Stein RJ, Kaouk JH (2013) Three-year oncologic and renal functional outcomes after robot-assisted partial nephrectomy. Eur Urol 64(5):744–750CrossRefPubMed
25.
go back to reference Raz O, Mendlovic S, Shilo Y et al (2010) Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery. Urology 75:277–280CrossRefPubMed Raz O, Mendlovic S, Shilo Y et al (2010) Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery. Urology 75:277–280CrossRefPubMed
26.
go back to reference Borghesi M, Brunocilla E, Schiavina R, Martorana G (2013) Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer 11(1):5–9CrossRefPubMed Borghesi M, Brunocilla E, Schiavina R, Martorana G (2013) Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer 11(1):5–9CrossRefPubMed
Metadata
Title
Oncological outcomes and prognostic factors after nephron-sparing surgery in renal cell carcinoma
Authors
Miguel Ángel López-Costea
Xavier Bonet
Jose Pérez-Reggeti
Begoña Etcheverry
Francisco Vigués
Publication date
01-05-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 5/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1217-z

Other articles of this Issue 5/2016

International Urology and Nephrology 5/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.